(MedPage Today) — The emergence of expert panels at the FDA — different from true advisory committees — raises questions regarding their lawfulness and credibility in relation to agency decisions, according to a viewpoint published in JAMA…
Source link : https://www.medpagetoday.com/washington-watch/fdageneral/119868
Author :
Publish date : 2026-02-13 16:00:00
Copyright for syndicated content belongs to the linked Source.
